Japan Intellectual Property Rights: ADENOSINE DEAMINASE BASE EDITOR AND METHODS FOR MODIFYING NUCLEOBASE IN TARGET SEQUENCE USING THE SAME

Japan, Nov. 4 -- BEAM THERAPEUTICS INC has got intellectual property rights for 'ADENOSINE DEAMINASE BASE EDITOR AND METHODS FOR MODIFYING NUCLEOBASE IN TARGET SEQUENCE USING THE SAME.' Other related details are as follows:

Application Number: JP,2025-093886

Category (FI): A61K31/7105,A61K35/12,A61K35/64,A61K35/74@A,A61K35/76,A61K35/761,A61K35/763,A61K36/09,A61K38/16,A61K38/46,A61K48/00,A61P43/00,105,A61P7/00,C07K14/195,C07K19/00,C12N1/21,C12N15/09,100,C12N15/09,110,C12N15/62@Z,C12N15/63@Z,C12N15/861@Z,C12N15/864,100@Z,C12N15/867@Z,C12N15/869@Z,C12N15/86@Z,C12N5/10,C12N9/16@Z,C12N9/78

Stage: Grant (IP right granted following substantive examination.)

Filing Date: June 5, 2025

Publication Date: Oct. 1, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.